🇺🇸 FDA

Drug profile · INN

tigecycline

TIGECYCLINE ACCORD

approved J01AA12
US status
approved
Patents linked
4
News articles
0

Quick answer

tigecycline (TIGECYCLINE ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN tigecycline
Brand TIGECYCLINE ACCORD
Route INTRAVENOUS
Formulation POWDER
ATC code J01AA12
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 8207361

    Tigecycline crystalline forms and processes for preparation thereof

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8198469

    Crystalline forms of tigecycline and processes for preparation thereof

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8198470

    Crystalline form II of tigecycline and processes for preparation thereof

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7871993

    Tigecycline crystalline forms and processes for preparation thereof

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is tigecycline?

tigecycline (TIGECYCLINE ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for tigecycline?

TIGECYCLINE ACCORD is a marketed brand name for tigecycline. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of tigecycline?

tigecycline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.